Adrenal Disease - Cushing's Syndrome Flashcards
What is Cushing’s Disease?
A condition where a pituitary adenoma secretes excessive ACTH.
What is Cushing’s Syndrome?
Signs and symptoms that develop after prolonged abnormal elevation of Cortisol.
Aetiology of Cushing’s Syndrome (4).
- Exogenous Steroids (Long-Term High-Dose).
- Cushing’s Disease.
- Adrenal Adenoma.
- Paraneoplastic Syndrome (SCLC).
What is Pseudo-Cushing’s?
Mimic of Cushing’s, often due to alcohol excess or severe depression. Differentiate using Insulin Stress Test.
Clinical Features of Cushing’s Syndrome - Appearance (5).
- Round Moon Face.
- Central Obesity.
- Abdominal Striae.
- Buffalo Hump (Fat Pad on Upper Back).
- Proximal Limb Muscle Wasting.
Clinical Features of Cushing’s Syndrome - Pathology (6).
- Hypertension.
- Cardiac Hypertrophy.
- Type II Diabetes Mellitus (Impaired Glucose Tolerance).
- Depression.
- Insomnia.
- Hypokalaemic Metabolic Alkalosis.
Clinical Features of Cushing’s Syndrome (2).
- Osteoporosis.
2. Easy Bruising and Poor Skin Healing.
Investigations in Cushing’s Syndrome (6).
- Test of Choice : Dexamethasone Suppression Test.
- 24 Hour Urinary Free Cortisol (Can’t Find Cause).
- Bloods - (Raised WCC + Low K+).
- MRI - Pituitary Adenoma.
- Chest CT - Small Cell Lung Cancer.
- Abdominal CT - Adrenal Tumours.
Dexamethasone Suppression Test Algorithm.
- Low-Dose 1mg Test : Positive.
2. High-Dose 8mg Test : Elucidate Underlying Cause.
Method of Dexamethasone Suppression Test.
- Dose of Dexamethasone at 10PM.
- Measure Cortisol and ACTH at 9AM.
- Aim : Check if Dexamethasone suppresses normal morning spike of Cortisol.
Rationale of Low-Dose Suppression Test.
Dexamethasone suppresses release of CRH, ACTH and consequently Cortisol - negative feedback.
Results of High-Dose Dexamethasone Suppression Test.
- Cushing’s Disease -suppresses Cortisol and ACTH.
- Adrenal Adenoma - suppresses ACTH and not Cortisol.
- Ectopic ACTH - does not suppress either Cortisol or ACTH.
Management of Cushing’s Disease.
Pituitary Tumour Resection.
Medical Management of Cushing’s Syndrome (4).
- Metyrapone - block steroid synthesis.
- Mifepristone - glucocorticoid antagonist.
- Ketoconazole - adsrenolytic agent.
- Pasireotide - binds to Somatostatin receptors.